MEI PHARMA INC (MEIP)
US55279B3015 - Common Stock
| MRQ (2023-12-31) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | 2020 (2020-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 5.17M | 16.90M | 15.70M | 8.50M | 12.30M | |||
| Marketable Securities | 54.31M | 83.80M | 137.50M | 144.90M | 170.30M | |||
| Receivables | 0.00 | 100.00K | 10.00M | 7.60M | 23.30M | |||
| Other Current Assets | 6.69M | 6.80M | 3.80M | 3.80M | 2.70M | |||
| Total Current Assets | 66.17M | 107.50M | 167.10M | 164.80M | 208.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 12.37M | 13.30M | 10.70M | 9.30M | 1.10M | |||
| Intangibles | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Total Non-Current Assets | 12.37M | 13.30M | 10.70M | 9.30M | 1.10M | |||
| TOTAL ASSETS | 78.54M | 120.80M | 177.80M | 174.10M | 209.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 6.66M | 13.90M | 11.70M | 9.30M | 6.10M | |||
| Accounts Payable | 1.38M | 6.10M | 7.90M | 6.40M | 2.40M | |||
| Other Current Liabilities | 0.00 | 300.00K | 4.80M | 4.50M | 5.20M | |||
| Total Current Liabilities | 8.04M | 20.30M | 24.40M | 20.20M | 13.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 11.01M | 75.80M | 101.00M | 104.40M | 118.90M | |||
| Total Non-Current Liabilities | 11.01M | 75.90M | 101.00M | 104.40M | 118.90M | |||
| TOTAL LIABILITIES | 19.05M | 96.20M | 125.40M | 124.60M | 132.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -360.69M | -406.00M | -374.20M | -319.70M | -278.40M | |||
| Additional Paid In Capital | 420.17M | 430.60M | 426.60M | 369.20M | 355.50M | |||
| Common Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 6.66M | 6.70M | 6.70M | 5.60M | 5.60M | |||
| Tangible Book Value per Share | 8.93 | 3.67 | 7.82 | 8.84 | 13.77 | |||
| Total Shareholders' Equity | 59.49M | 24.60M | 52.40M | 49.50M | 77.10M | |||
| TOTAL LIABILITIES AND EQUITY | 78.54M | 120.80M | 177.80M | 174.10M | 209.70M | |||
| Statistics | ||||||||
| Current Ratio | 8.23 | 5.30 | 6.85 | 8.16 | 15.12 | |||
| Return On Assets (ROA) | 25.26% | -26.36% | -30.62% | -23.73% | -22.49% | |||
| Return On Equity (ROE) | 33.35% | -129.43% | -103.91% | -83.45% | -61.18% | |||
| Return On Invested Capital (ROIC) | 17.79% | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 113.84% | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 113.84% | N/A | N/A | N/A | N/A | |||
All data in USD